Latest News and Events
Filter by
Selections
October 29, 2012
Arrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without Toxicity Using Subcutaneous Formulation of Dynamic Polyconjugate siRNA Delivery System
Read MoreOctober 16, 2012
Arrowhead Research Receives Notice of Patent Allowance for New Formulation of DPC siRNA Delivery System Showing 500-Fold Increase in Potency
Read MoreSeptember 5, 2012
Arrowhead to Present at Rodman and Renshaw Annual Global Investment Conference
Read MoreAugust 30, 2012
Arrowhead Completes Enrollment in Phase 1b Trial of RNAi Drug Candidate CALAA-01
Read MoreAugust 13, 2012
Arrowhead Raises $6.2 Million through Registered Direct Offering of Common Stock and Warrants
Read MoreAugust 9, 2012